The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 trial of brentuximab vedotin in combination with gemcitabine for pediatric and young adult patients with relapsed or refractory Hodgkin lymphoma, a Children’s Oncology Group report.
 
Peter D. Cole
No Relationships to Disclose
 
Monika Metzger
No Relationships to Disclose
 
Richard A. Drachtman
Research Funding - Amgen; AstraZeneca; Mast Therapeutics
 
Terzah M. Horton
No Relationships to Disclose
 
Xiaowei Liu
No Relationships to Disclose
 
Charlotte H. Ahern
No Relationships to Disclose
 
Charles Minard
No Relationships to Disclose
 
Elizabeth Fox
No Relationships to Disclose
 
Susan Blaney
Research Funding - Genentech (Inst)
 
Brenda Weigel
Travel, Accommodations, Expenses - Genentech; Lilly/ImClone; Roche/Genentech
 
Kara M. Kelly
No Relationships to Disclose